Bear and Monk Debunk: GLP-1s, Hype and Hormones
AKA: That post where we explain what GLP-1 drugs actually do, and why your cousin’s Facebook rant is full of it.
I’m really excited this week to bring you a collaborative piece with one of my absolute debunking heroes - The Bear. I discovered Bear (yes, he wishes to remain anonymous, and who can blame him!) over on Twitter a few years back, and fell in love with his wit, his withering take-downs, and his poetic use of language in pursuit of dodgy politicians.
Just this week, he has blown apart Reform’s rage-baiting nonsense about immigrants and TV licences.
Bear and I share a passion for cutting through divisive politics and media and helping people access the truth behind the claims.
So we decided to team up to cover the thorny issues around weight loss drugs.
I’ll be taking the science lead on this post - explaining what GLP-1 drugs are, how they work, what we know (and don’t yet know), and why the conversation matters, while Bear will be handling the myth breakdowns - where the conspiracies come from, why they’re so sticky, and how they fit into the broader culture of panic, shame, and medical mistrust.
There’s no shortage of noise around GLP-1 drugs right now.
Whether it’s Ozempic, Wegovy, Mounjaro, or whichever weekly injection is making headlines this week, the narrative has veered wildly from medical breakthrough to miracle cure to metabolic horror show - sometimes in the space of a single scroll.
Depending on who you believe, these drugs are either saving lives or destroying the world, one restaurant at a time. They’re either the future of obesity treatment or the latest scheme to line Big Pharma’s pockets. One moment they’re being hailed as a way out of the chronic illness spiral; the next, they’re accused of being endocrine poison wrapped in a syringe.
So - what’s true? What’s myth? What’s risk? And what’s just conspiracy-caked panic?
Bear wrote a post last year about his own journey with weight loss - and it involved everything from therapy to strength training to a high-protein diet, layered with all the invisible labour and internal rewiring that comes from unpicking years of shame, stigma, and bad science. So when people say “it’s just about eating less and moving more,” he tends to look at them the way a cat looks at a cucumber.
Because it’s not simple. Bodies aren’t spreadsheets. And the louder the bad takes get, the more important it becomes to root the conversation in both evidence and empathy.
This post is structured as sort of an escalating FAQ - starting with the basics, and working our way up to the more, shall we say, “creative claims”. Each section opens with a key question or myth, followed by my scientific response, and then Bear will round things out with some myth-busting context: what’s driving the belief, why it spreads, and what it tells us about the ecosystem it lives in.
1. What are GLP-1 drugs, and how do they work?
Let’s start with the basics - because despite their ubiquity in headlines and hashtags, a surprising number of people are still wildly guessing. GLP-1 drugs were originally developed for managing type 2 diabetes but are now widely used in the treatment of obesity. They work by mimicking a hormone that affects appetite, blood sugar, and digestion - but what does that actually mean in practice?
Emma’s response:
GLP-1 is a naturally occurring hormone that is released by the gut when we eat. It has various effects on the body:
Stimulates Insulin Secretion: Carbohydrates are broken down into sugars, and insulin helps lower your blood sugar levels by moving the sugars from your bloodstream into your cells, where they are used for nourishment and energy.
Suppresses Glucagon Release: GLP-1 also inhibits the release of glucagon, a different hormone that raises blood sugar by signalling to the liver to release stored glucose if your body needs more energy.
Slows stomach emptying: By slowing down digestion, your body releases less sugar from the food you eat into your bloodstream.
Increases how full you feel after eating (satiety): GLP-1 affects the areas of your brain that process hunger and satiety, so you don’t feel hungry and you feel full up for longer.
While using GLP-1 directly to try and treat diabetes wasn’t successful, once scientists modified the structure slightly, they were able to show it behaved just like GLP-1 in the body, producing all the same effects. This modified compound was called Semaglutide
Semaglutide was originally developed as a treatment for Type 2 Diabetes (Ozempic) and then as a weight-loss drug (Wegovy).
Bear’s analysis:
The confusion here isn't really about complicated science - it's about GLP-1 drugs entering public consciousness through celebrity whispers and tabloid headlines rather than actual medical communication. Before most people knew what semaglutide was, they knew it as "Hollywood's secret weapon."
Weight loss has always been fertile ground for magical thinking and moral panic. Add a pharmaceutical intervention that actually works, and you get people convinced it's either a miracle cure or liquid Satan, depending on their particular corner of the internet.
The complexity Emma describes gets flattened into "just eat less and move more" (ignoring hormonal reality) or "Big Pharma dependency schemes" (ignoring decades of research). This confusion serves certain interests: wellness grifters selling overpriced alternatives, and a diet industry that's spent decades convincing us weight is a moral failing rather than a medical issue.
2. What are the common side effects - and how are they monitored?
As more people begin using GLP-1 drugs, questions about side effects are increasing - particularly around nausea, digestion, and long-term use. What do we know about the most common adverse effects? How are these tracked across large populations? And what should patients expect when starting treatment?
Emma’s response:
The most common side effects of GLP-1 drugs, particularly when you first start taking them, include:
Loss of appetite.
Nausea.
Vomiting.
Diarrhoea.
The advice is to eat slowly, have smaller, lower-fat meals, and try not to be too active straight after a meal.
Other, less common side effects include dizziness, headaches, increased heart rates and irritation on the skin at the site of the injections.
The delay in your stomach emptying can impact how well other drugs are absorbed, so it’s vital to discuss this with your doctor if you are on other medications.
One other important “side effect” to be aware of is that by reducing your food intake, you may end up not getting enough protein to prevent muscle loss or the necessary micronutrients. So it is important to ensure you maintain a healthy diet while taking GLP-1 drugs, prioritising protein and fresh fruit and vegetables.
Prioritise balanced meals. Be sure to include protein, whole grains, and healthy fats to maintain proper nutrition.
Drink plenty of fluids. Ensure you remain hydrated.
Don’t skip meals. Aim to eat regularly to ensure that your body gets essential nutrients. Try eating smaller meals throughout the day to avoid potential discomfort.
Listen to your body. Stop eating when you’re full, but ensure you consume enough calories to meet your nutritional needs.
As with all medications, doctors and patients are encouraged to report side effects to the Yellow Card scheme in the UK, MedWatch in the USA, or their equivalents in other countries. This allows for drugs and vaccines to be monitored once they are approved to pick up very rare risks that may not show up in clinical trials. While clinical trials may include a few thousand patients, rare, 1 in a million type side effects can only be picked up through this type of monitoring. When these are picked up this way, it shows the system is working - not that trials “failed” or “missed side effects”!
Bear’s analysis:
The side effects Emma lists - nausea, vomiting, diarrhoea - aren’t all that shocking for a drug that literally slows stomach emptying. But online, they morph into “proof” that GLP-1s are poison, rather than… basic human physiology.
What’s a bit annoying is how selectively that logic gets applied. The same person aggressively throwing themselves onto a fainting sofa over “Ozempic nausea” is often chugging unlabelled supplements or doing TikTok detoxes that proudly claim, “you’ll feel worse before you feel better.” Apparently, it’s only a problem if it comes with a prescription.
Meanwhile, the safety monitoring Emma describes - Yellow Card, MedWatch - is the system working. Rare side effects get logged, studied, and then acted on. That’s not a scandal, that’s literally just how post-market surveillance is supposed to work.
But “medication monitored for safety” doesn’t go viral quite the way “OZEMPIC HORROR STORY 😱💀” does, and so, people fear the transparent stuff while swallowing mystery powders from strangers on the internet.
Muscle loss? That’s a real risk, and exactly why actual medical advice matters more than influencer reels.
3. Are there serious long-term risks - like cancer or organ damage?
Concerns about long-term risks - particularly links to cancer, thyroid problems, or kidney function - have become a major sticking point in public discourse. Are these fears based on solid evidence, early warning signs, or lingering unknowns?
Emma’s response:
There are a number of potential serious risks linked to GLP-1 drugs, which I’ll try and cover without the fear mongering!
Pancreatitis
While rare, GLP-1 has been linked to inflammation of the pancreas, and this week, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) reported on 113 cases of pancreatitis and one death from patients using Ozempic or Wegovy. Other GLP-1 drugs also had pancreatitis reports and deaths associated with them.
It is important to note that there is no evidence so far that GLP-1 CAUSED the pancreatitis, as it occurs in the general population at a rate of 560 cases per million people and is linked to other factors such as alcohol use too.
Further studies will now take place to try and establish if there is a causal link or not between GLP-1 drugs and pancreatitis
Gallstones and gallbladder inflammation
GLP-1 medications have been associated with an increased risk of gallbladder issues, particularly at higher doses and with longer durations of use.
It is unclear if the issues are caused by the drug itself or the rapid weight loss associated with the use of the drug.
Again, these are rare complications but worth knowing about to ensure issues are raised with your doctor if you have concerns
Acute kidney damage
While GLP-1 medications have been shown to be really beneficial for diabetes patients with chronic kidney disease, there have been some reported cases of acute kidney damage associated with the drugs.
Some cases appear to be linked to dehydration in patients using GLP-1 drugs, so it is really important to stay hydrated, especially if suffering from vomiting and diarrhoea.
Thyroid tumours
Early animal studies highlighted a possible link between GLP-1 drugs and thyroid cancer in rats, but the data remains unclear on whether there is an increased risk in humans.
It has been studied across 10,000’s of patients over 10 years, with some studies showing an increased risk and others not. So, as a precaution, those with a family history of medullary thyroid cancer are not recommended to take GLP-1 drugs.
Bear’s analysis:
This is where real medical nuance collides with full-blown conspiracy fodder. Emma’s phrasing - “no evidence GLP-1 caused,” “unclear if linked,” “data remains unclear” - is exactly what honest, grown-up science sounds like, but to conspiracy-minded ears, any level of uncertainty just screams cover-up.
Take the thyroid cancer bit - rats got tumours, so researchers flagged it and launched years of large-scale studies. That’s exactly what’s supposed to happen. But online? “They knew it caused cancer and hid it!”
The same people panicking over theoretical risks often ignore the very real dangers of untreated obesity - heart disease, diabetes, stroke, and actual cancer. It’s like refusing a seatbelt because of the one-in-a-million chance of being trapped.
Pancreatitis reports? 113 flagged out of millions of doses - that’s not a red flag; that’s pharmacovigilance doing its job. But try explaining statistical context to someone already shouting, “mass poisoning.”
Risk assessment isn’t about perfection - it’s about trade-offs, and for many people, the risks Emma outlines are far lower than the risks of doing nothing.
4. Are pharmaceutical companies pushing GLP-1 drugs for profit and long-term dependency?
This question sits at the crossroads of public health and corporate accountability. Critics argue that GLP-1 drugs are being over-promoted as a permanent solution, creating a long-term customer base. Is there substance to these claims - or is this just what long-term treatment for chronic conditions looks like?
Emma’s response:
In short, no.
No one is “pushing” GLP-1 drugs on anyone.
Real world data shows that the majority of people taking GLP-1 drugs actually stop taking them within two years. This may be due to the side effects, because people have lost weight and decided they don’t need them anymore, or that they want to be able to enjoy food again. But whatever the reason, we are not seeing evidence of “long-term dependency”
Ultimately, these are drugs that have been proven to be extremely successful in helping people manage their diabetes and also lose weight. But they aren’t a quick fix. Once you stop taking them, they won’t work anymore (obviously!), just like any other drug. Of course, for some people, they may decide that they’ve lost enough weight and that they can maintain that with lifestyle choices alone, as the data above suggests. GLP-1 drugs aren’t addictive, and people can and are choosing to come off them whenever they feel ready.
Bear's analysis:
The classic “Big Pharma wants you dependent” line is back - as if pharmaceutical companies invented chronic conditions needing ongoing treatment. Should we add insulin to the conspiracy list, too?
The data that Emma has linked to that shows that most people stop after two years is telling, because it hardly sounds like the strategy of an evil corporate overlord building lifelong customers. It’s almost like… they work, and then people don’t need them anymore. So weird.
The wellness industry, on the other hand - forever railing against “Big Pharma” - runs on the exact dependency model it claims to hate. Keep buying the powders. Stick to the protocols. Never quite arrive, but always pay for the journey.
And yes, pharma companies want profit, so does every business. But they’re required to prove their products work and are safe. If they were just chasing cash with no oversight, they’d be selling unregulated supplements, not sinking billions into trials.
5. Was the approval process rushed or influenced by Big Pharma?
The speed of medical innovation often invites scrutiny - especially in a post-COVID world. Some worry that GLP-1 drugs were pushed through the regulatory process too quickly. What did that process involve, and were corners cut to fast-track approval?
Emma’s response:
The idea of using GLP-1 to treat diabetes has been around since the early 1990’s.
Ozempic trials for diabetes in humans began in 2008, with larger trials beginning in 2016.
The FDA approved Ozempic to treat diabetes in 2017, using the data from 8 different trials, in over 8000 patients, across 30+ countries.
Four years later, in 2021, a successful trial was run for patients who were obese but not diabetic. It was approved by the FDA for weight loss later that year, and by the European Medicines Agency (EMA) in 2022.
These trials took place over 15 years - that is not a process that has been “rushed”! The level of scrutiny that goes into setting up and running clinical trials, and then getting your drug approved by multiple agencies across the world (who don’t always agree), is incredibly intense.
Bear’s analysis:
Fifteen years of clinical trials across eight different studies and 8,000 patients is "rushed"? By that logic, the Beatles were a flash in the pan and the Roman Empire was a weekend project.
This is what happens when people's sense of medical timelines gets completely warped. COVID vaccines genuinely were developed quickly (for very good reasons), and now everything pharmaceutical feels suspiciously speedy. Never mind that GLP-1 research predates TikTok, the iPhone, and probably half the people posting conspiracy theories about it.
The timeline Emma explains reads like a perfect “how-to guide” in methodical medical development, but in the age of overnight Amazon delivery and instant everything, a decade-plus of careful research apparently counts as "rushed."
The regulatory agencies that approved these drugs - FDA, EMA, and others - don't always agree on everything. When they do align on approval, that's not evidence of corruption. That's what scientific consensus looks like.
6. Are doctors being incentivised to prescribe drugs over lifestyle interventions?
The narrative that doctors are under pressure - or even bribed - to prioritise medication over diet, exercise, or behavioural therapy is a familiar one. How do medical professionals decide when to prescribe GLP-1s, and is there any truth to the idea of systemic bias in favour of pharmaceutical solutions?
Emma’s response:
On the contrary - the clinical trials and now prescribing advice all require “diet and lifestyle” advice to be given alongside the drug.
The UK NICE guidance state:
Diet and lifestyle advice: At each point, reinforce advice about diet and lifestyle.
The EMA state:
Ozempic is a diabetes medicine used with diet and exercise to treat adults whose type 2 diabetes is not satisfactorily controlled.
The trials all involved giving the GLP-1 drug or placebo PLUS diet and lifestyle coaching. For example, the trial looking at weight loss:
In this double-blind trial, we enrolled 1961 adults with a body-mass index of 30 or greater, who did not have diabetes, and randomly assigned them, in a 2:1 ratio, to 68 weeks of treatment with once-weekly subcutaneous semaglutide (at a dose of 2.4 mg) or placebo, plus lifestyle intervention
Right from the start, these drugs were not meant to replace improvements to diet and lifestyle - they are used ALONGSIDE those improvements.
Bear's analysis:
The “doctors are pushing pills instead of lifestyle changes” claim collapses spectacularly the moment you check the actual guidance. As Emma points out, lifestyle advice is literally required alongside GLP-1 prescriptions. It’s not either/or - it’s both.
This conspiracy heavily relies on the idea that doctors, trained in human biology and dealing daily with the consequences of poor lifestyle, are somehow clueless or corrupt. Apparently, after years of being told to “do something” about obesity, offering a treatment that actually helps is now suspicious too.
The truth is that many patients have tried diet and exercise for years. GLP-1s aren’t a shortcut - they’re what makes change sustainable. The meds don’t replace healthy habits; they just help make them possible.
But admitting that would mean accepting that some people need medical help, while others get by on willpower. And that challenges the comforting myth that weight is just a moral failing. It’s not. It’s complex. And for once, doctors can treat it as such.
7. Are GLP-1s being used for population-level obesity control?
This theory suggests that governments, health systems, or corporations may be promoting GLP-1 drugs not just for individual care, but as a tool of population management - raising concerns about autonomy, consent, and public health strategy. Is this grounded in any real policy direction?
Emma’s response:
None whatsoever as far as I can see! I’ll let Bear dig into this conspiracy theory….
Bear’s analysis:
Now we’re in the deep end of the conspiracy pool - where a medication becomes a shadowy plot for population control. The theory? GLP-1 drugs are being used to make people docile, dependent, or mysteriously more controllable. The logic is fuzzy: thinner people are easier to oppress? Pharma dependency equals mass compliance. It folds under even mild scrutiny.
The irony of this is that many of the same people pushing this narrative also rage about government inaction on obesity and health costs. So, doing nothing is negligence, but doing something is a globalist plot. How terribly convenient.
The boring reality is that GLP-1 drugs are expensive, tightly regulated, and prescribed one patient at a time. If governments wanted to control obesity at scale, they’d start with sugar taxes or town planning - not £200-a-month injections.
But “doctors treat chronic illness” doesn’t trend like “THEY’RE MEDICATING THE MASSES.” One requires nuance. The other just needs caps lock.
8. Do these drugs contain hidden or harmful ingredients?
Here we enter classic conspiracy territory: the belief that GLP-1 drugs are concealing toxic or experimental ingredients not disclosed to patients or regulators. How transparent is the formulation process, and how realistic are these concerns?
Emma’s response:
Ingredients with complicated-sounding names can often sound scary, but unlike supplements and wellness “cures”, the ingredients found in approved medicines are incredibly well-known, well-monitored and well-tested.
Ozempic's formulation includes:
Semaglutide – The active ingredient that mimics the GLP-1 hormone
Sodium Chloride – This ensures it is compatible with the body's cells.
Water – This is the solvent that dissolves all the ingredients.
Disodium phosphate dihydrate - A buffer to maintain the stability and pH of the drug
Propylene glycol - Helps to reduce clogging
Phenol - A preservative that also serves as a disinfectant and anti-microbial agent.
The ingredients in any medication can be found in the paperwork that comes with the drug, and while some of the chemical names will be unfamiliar to most, that doesn’t make them harmful or scary!
Drug manufacturing facilities are regularly inspected, every batch of drugs gets tested to ensure purity, and all this information is provided to the regulators. It is an incredibly tightly controlled system, and it simply is not possible to “hide” ingredients in there - even if they wanted to (why would they want to??)
Ironically, the people who tend to peddle these types of conspiracy theories about pharmaceutical drugs are often the people selling “wellness cures” that don’t undergo any kind of regulation or oversight and so can, and often will, contain hidden and/or harmful ingredients.
Bear’s analysis:
Nothing rattles an extremely online conspiracy theorist like “disodium phosphate dihydrate.” Never mind that it’s a basic buffer found in food and toothpaste - it sounds sinister, so it must be. This is chemophobia 101: if you can’t pronounce it, it’s clearly poison. (By that logic, we should ban dihydrogen monoxide - also known as water.)
What’s very noteworthy is the role reversal. The people making an almighty racket over ingredients in rigorously tested, tightly regulated medications are the same ones chugging mystery powders from Instagram. Transparency is terrifying, but “proprietary blends” are apparently fine.
Ozempic’s ingredients are public, dull, and predictable: semaglutide, salt, water, a buffer, and a preservative. Not exactly a mind control serum.
Meanwhile, that “all-natural” supplement promising to fix your life? No oversight, no ingredient disclosure, no problem. If you’re worried about hidden additives, maybe start with the industry that’s allowed to hide them.
9. Is the current shortage a manufactured crisis to drive up demand?
Shortages of GLP-1 drugs have made headlines around the world, fuelling speculation that the supply chain is being deliberately manipulated to increase demand or pricing. Is there any evidence of this - or is it simply a case of demand outstripping supply?
Emma’s response:
Not at all - this is all about demand. Since the approval of GLP-1 for weight loss, demand has surged not just from diabetes patients or even obese patients, but also driven by celebrities and social media promoting their use for weight loss.
Novo Nordisk ramped up production to run their factories 24/7 and took on 10,000 more staff in 2023 to cope with the increased demand!
In 2022, the FDA included 4 GLP-1 drugs in their shortage list, which meant that it became legal for licensed pharmacies or pharmacists to make their own version of the drug for their patients (known as compounding), using imported ingredients. This comes with many quality control issues, but is seen as a necessity to ensure patients who need medications can still access something while there’s a global shortage.
However, earlier this year, the shortages were declared to be over by the FDA, meaning these compounded versions are no longer legal. This has led to issues with costs rising for patients who were using these cheaper compounded drugs, but it also means that patients now know they are getting quality-controlled medication with the correct dosage and other ingredients.
Bear’s analysis:
The “manufactured shortage” theory hinges on the idea that pharmaceutical companies deliberately chose to… sell less of their most profitable product. It’s like claiming Apple limits iPhone sales just to create buzz. The math doesn’t math.
Emma’s timeline tells a different story: demand surged thanks to celebrity use and social media hype, factories ran 24/7, 10,000 new staff were hired, and regulators greenlit emergency compounding to fill the gap. That’s not a conspiracy - that’s capitalism playing catch-up with virality.
The compounding piece is key. When supplies dipped, the regulators allowed pharmacies to make their own versions - not exactly what you’d expect from a system engineering artificial scarcity. Once production stabilised, the workaround ended. That’s basic supply management, not grand design.
And let’s be honest, people wanted the drug because it worked. The real mystery isn’t the shortage - it’s how conspiracy theorists can keep ignoring the obvious while demanding secret motives behind every supply chain glitch.
10. Are GLP-1s being used to suppress “natural” or non-medical weight loss solutions?
Some argue that the rise of GLP-1 drugs is part of a larger effort to delegitimise non-pharmaceutical interventions - like diet, community support, exercise, or mental health care - in favour of profitable treatments. How fair is that claim, and what does it miss about the role these drugs actually play?
Emma’s response:
Doctors and scientists have been “pushing” natural weight loss solutions such as diet and exercise for decades. You won’t find a single doctor telling patients not to bother with that and just pop this pill instead!
Again, ironically, there are many scammers out there trying to sell “wonder weight loss” pills, promising all the results with no effort. But they aren’t genuine doctors, scientists, or even pharmaceutical companies!
There are no “natural” or non-medical weight loss solutions, beyond eating a healthy, balanced diet and maintaining an active lifestyle. And the doctors prescribing GLP-1 drugs are also advising patients on how to do that. The drugs are intended to work alongside these lifestyle factors and are in no way meant to “replace” that advice.
I feel that the topic of pharmaceutical profits requires its own full-length explainer/debunker! But in short, pharmaceutical companies need to make profits (just like every other company in existence!) to fund the research to make the next generation of life-saving drugs. For every one wonder drug that makes it to market like Ozempic, there are 100s that never get that far, but had the potential that made the research worthwhile. It takes decades to develop drugs from an original idea to a blockbuster drug, with most drugs never making it that far.
So yes, pharmaceutical companies do aim to make a profit on the drugs that succeed. They aren’t charities, and if they didn’t do it, we wouldn’t have lifesaving vaccines and medicines. Of course, there is always legitimate debate to be had over how much profit is acceptable, how drugs can be made available to those with less money, and the absurdity of the costs in the USA, but the narrative that the pharmaceutical industry should not be profitable ignores the realities of drug development.
Bear’s analysis:
This conspiracy has legs because it flatters people. It says health is a moral choice, that the virtuous succeed through willpower and spinach, and anyone reaching for medical help has somehow failed.
But if “natural” solutions were enough, we wouldn’t be here. People already know the basics - eat better, move more, sleep well - and still struggle. Not because they’re lazy, but because bodies are complex, life is chaotic, and biology isn’t a self-help book.
As we’ve already noted, GLP-1s don’t replace healthy habits - they make them sustainable. For many people, they’re the first thing that’s ever quieted the food noise long enough to change their routines.
Meanwhile, the people shouting about “natural alternatives” are often selling unregulated powders with zero evidence behind them. Big Pharma’s profit motive gets dissected to death - but somehow, the wellness influencer flogging detox teas gets a free pass.
The truth is, most people aren’t choosing between nature and medicine. They’re choosing between staying stuck and finally seeing progress. GLP-1s don’t suppress natural solutions. They help people finally put them into practice.
We hope you’ve enjoyed this collaboration! Do let us know, and we may do more together in the future.👍🏻
Excellent guide to keeping calm & carrying on. My daughter for at least the last 15 years has tried a myriad of diets & interventions. Been to her GP at least three times often in tears to be told here's 12 weeks at the gym here's some tablets to help you poo orange fat here's an appointment with the dietitian & here's the health NHS food plate. The 'fat-jab' is working for her, she keeps to the 2.5 dose with no intentions of upping dosage and we are ecstatic that at long last her weight is reducing. She feels it is re-educating thoughts about constantly thinking about food to feeling indifferent about it. She is not lazy she knows what foods to eat she walked daily but nothing apart from this medication was working. Thank you both for taking the time to remove the scare and turn it into care.
In my opinion, these medications are truly life changing for so many people.
I think every social media ‘expert’ should be made to read this article. They try guilt tripping users, spread fear and anxiety by posting ridiculous theories about the dangers of these drugs, the side effects, the long term effects of use and how the weight will just’ pile back on’ when the user stops taking them. They spread fear with their usual conspiracy theories about the contents of the drug causing unnecessary fear.
The other so called ‘expert’ is the one who clearly demonstrates their ignorance by declaring users are cheating! All that is needed is to keep their face out of the fridge and get off their lazy ar$e and do some exercise. Oh if life were so simple.
A great collaboration by you both.